Condition
Mirogabalin
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07307170Not ApplicableRecruiting
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
NCT07157852Not ApplicableRecruiting
The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia
NCT06711978Not ApplicableNot Yet Recruiting
Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors
Showing all 3 trials